How big is the Multiple Sclerosis Therapeutics Market?

The Multiple Sclerosis Therapeutics Market size is expected to reach USD 31.03 billion in 2024 and grow at a CAGR of 3.87% to reach USD 37.52 billion by 2029. Read More

What is the current Multiple Sclerosis Therapeutics Market size?

In 2024, the Multiple Sclerosis Therapeutics Market size is expected to reach USD 31.03 billion. Read More

Who are the key players in Multiple Sclerosis Therapeutics Market?

Biogen Inc., Novartis AG, Merck KGaA, Sanofi S. A. and Acorda Therapeutics, Inc. are the major companies operating in the Multiple Sclerosis Therapeutics Market. Read More

Which is the fastest growing region in Multiple Sclerosis Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Multiple Sclerosis Therapeutics Market?

In 2024, the North America accounts for the largest market share in Multiple Sclerosis Therapeutics Market. Read More

What years does this Multiple Sclerosis Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Multiple Sclerosis Therapeutics Market size was estimated at USD 29.83 billion. The report covers the Multiple Sclerosis Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Multiple Sclerosis Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Multiple Sclerosis Therapeutics Market Share

Statistics for the 2023 & 2024 Multiple Sclerosis Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Multiple Sclerosis Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Multiple Sclerosis Therapeutics Industry

The multiple sclerosis therapeutics market is moderately competitive, with few players. These big pharmaceutical companies focus on pipeline drugs for multiple sclerosis. With the rising R&D investment in the pharmaceutical industry, more companies may enter the market, and the competition may increase. Some major companies currently dominating the market are Biogen Inc., Novartis AG, Merck KGaA, Sanofi, and Acorda Therapeutics Inc.